FEATURED POST
What You Can Learn from 7 Theme Fusion Success Stories
Nam lacinia arcu tortor, nec luctus nibh dignissim eu. Nulla sit amet maximus nulla. Pellentesque a accumsan eros, ac molestie nulla. Morbi interdum in neque vitae vulputate.
Newsletter, June 2024
Dear Reader, Imagine a world where every child, regardless of their condition, has access to safe, effective, and child-friendly therapies. This [...]
RACE Act accelerates Paediatric Oncology Drug Testing, FDA reports
The U.S. Food and Drug Administration (FDA) has reported a significant increase in the number of planned studies to test drugs [...]
CVBF Attends EJP RD Final Conference in Bari
CVBF was among the participants at the European Joint Programme on Rare Diseases (EJP RD) Final Conference, held on 27-28 May 2024 [...]
CVBF at the ERAMET Kick-Off Meeting
Namur, Belgium - CVBF participated in the kick-off meeting of the ERAMET project on March 4-5 in Namur that was [...]
29 February 2024, Rare Disease Day
29 February is Rare Disease Day, falling on the rarest date of the calendar. This is an opportunity to raise [...]
CVBF’s Scientific Director to Speak at Rare Disease & Orphan Drugs Congress
Giovanni Migliaccio, Scientific Director of CVBF and member of the Board of Directors of the European Paediatric Translational Research Infrastructure [...]
CVBF’s Head of Project Development, Arianna Bertolani, to Attend World EPA Congress 2024
Our Head of Project Development, Arianna Bertolani, as a member of the TEDDY Network Board of Directors, will be attending [...]
Advanced Therapies: A Researcher’s Perspective on ATMPs – Insights from Giovanni Migliaccio
Giovanni Migliaccio, the Scientific Director of CVBF, recently participated at the MEP Interest Group 2023 Conference organized by the European Alliance for Transformative Therapies (TRANSFORM) [...]
EUCROF Paediatric Training: Our CEO’s Vision for Advancing Paediatric Clinical Research
In the ever-advancing world of clinical research, staying at the forefront of knowledge and practices is imperative. On 12 September 2023, our CEO, Donato Bonifazi [...]
Developed tools for Rare Diseases researchers – ERICA & EJP RD Joint Conference
Bonka Georgieva, CVBF's Project Manager, presented at the "ERICA & EJP RD Joint Conference" held in Amsterdam. The event served as a platform for advancing [...]
XVI Foresight Training Course
Arianna Bertolani, our Head of Project and Development, will participate, as a speaker at the 16th Foresight Training Course entitled "Repurposing to cover unmet needs: [...]
CVBF’s Expertise in Phase I Clinical Trials: A Commitment to Excellence
Phase 1 trials, be they conducted on healthy volunteers or patients, focus on generation of initial knowledge on tolerability, safety and PK/PD.. These trials determine [...]
Unveiling the New and Improved Website
In today's fast-paced digital world, a company's online presence is often its first point of contact with customers. It's not just a virtual business card [...]